Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0000950170-25-080310

Director sold 1,392 shares at $7.25 ($10,096)

  • Director acquired 4,800 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Altmeyer Anne Director 2025-05-30 Sale 10b5-1 −1,392 $7.25 $10,096 1,391 D
Altmeyer Anne Director 2025-05-30 Grant or award 10b5-1 +4,800 6,191 D
Derivatives
Altmeyer Anne Director 2025-05-30 Grant or award · Stock options (right to buy) 10b5-1 +16,000 16,000 D
Open-market sales · 1,392 sh · avg $7.25 · $10,096
Loading xslF345X05/ownership.xml…